SHAGHAYEGH REZAIE: Open Payments
NPI 1457944076 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,856 in 17 payments from 13 companies in 2025. Trend: 2023 $1,291 · 2024 $2,310 · 2025 $1,856
Food & beverage: $1,856
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC | 3 | $300 |
| Daiichi Sankyo Inc. | 2 | $246 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $212 |
| Teva Pharmaceuticals USA, Inc. | 1 | $135 |
| GENZYME CORPORATION | 1 | $122 |
| Grifols USA, LLC | 1 | $116 |
| GlaxoSmithKline, LLC. | 1 | $110 |
| Alnylam Pharmaceuticals Inc. | 1 | $108 |
| Novocure Inc. | 1 | $107 |
| Aveo Pharmaceuticals, Inc. | 1 | $104 |
Products named: BARRIGEL, DATROWAY, AUSTEDO XR, FABRAZYME, Prolastin-C Liquid, JEMPERLI, AMVUTTRA, Optune Gio.
Industry payments across TX — which companies pay providers there.
